Intracranial hypertension following intrathecal administration of liposomal cytarabine.
Lunskens
S
S
Lammertijn
L
L
Deeren
D
D
Bergmans
B
B
Maertens
J
J
Vandenberghe
R
R
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000134:cerebrospinal fluid; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects* / Q000134:cerebrospinal fluid; D006801:Humans; D007278:Injections, Spinal; D019586:Intracranial Hypertension / Q000134:cerebrospinal fluid / Q000139:chemically induced*; D008081:Liposomes; D008279:Magnetic Resonance Imaging; D008297:Male; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000134:cerebrospinal fluid / Q000150:complications / Q000188:drug therapy
D000964:Antimetabolites, Antineoplastic; D008081:Liposomes; D003561:Cytarabine